Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Martin Posgay who wrote (986)	3/27/1999 8:22:00 AM
From: vestor	Respond to of 1837

Some interesting bits of news: G. Gordon Liddy discussed the benefits of Cenestin and had a negative slant on Premarin. A little free press.. I wonder how many investors are aware of the Tamoxifin submission before the FDA. I have heard that this too is a block buster if approved. I am being told that one of the dosages permitted of Cenestin is not available with Premain and that dosage is highly desireable by doctors... Can anyone confirm ? Does anyone know of the financial impact to the companys bottom line for the two other drug approvals the week before ? There are also three other ANDA's well along in the FDA pipeline. Does anyone know what they are and their impact ? Given recent events and in consideration of upcoming events this company is not an $11. stock. Perhaps we may touch upon $10. soon as momentum players take profits. Are there any TA people with thoughts as to a good buyin price ? When considering upside potential vs downside risk it seems it is reasonable to accmulate shares at these levels.... IMHO.....

To: Martin Posgay who wrote (986)	3/27/1999 6:08:00 PM
From: Bullhorn	Respond to of 1837

Martin-Agreed.....we should check the new short count???

To: Martin Posgay who wrote (986)	3/29/1999 12:34:00 AM
From: Haolin Ni	Read Replies (2) \| Respond to of 1837

>Should be around $15 to $17 next week. Usually the fund managers wait until the price settles down to a stable level before jumping into the market.< Please check the charts of ENMD and any other Biotech stocks after they had a big run. I guess you rarely investing in biotech stocks before when you have such a dream. DRMD has little money in hand for production and distribution. No one like to buy DRMD over $15 any more. I really hope it could reach there so my friend and I could increase the short position.